$THMO
ThermoGenesis Holdings, Inc. Stock $thmo

$thmo Overview Financials Valuation SEC Filings Company Website

2020 Q4 Form 10-Q Financial Statement

#000143774920023634 Filed on November 12, 2020

Income Statement

Concept	2020 Q4	2020 Q3	2019 Q3
Revenue	$1.950M	$2.355M	$4.058M
YoY Change	13.37%	-41.97%	30.36%
Cost Of Revenue	$1.060M	$844.0K	$2.163M
YoY Change	-6.19%	-60.98%	-12.0%
Gross Profit	$890.0K	$1.511M	$1.895M
YoY Change	50.85%	-20.26%	189.31%
Gross Profit Margin	45.64%	64.16%	46.7%
Selling, General & Admin	$1.760M	$1.844M	$1.641M
YoY Change	-44.83%	12.37%	-17.08%
% of Gross Profit	197.75%	122.04%	86.6%
Research & Development	$540.0K	$750.0K	$584.0K
YoY Change	-15.63%	28.42%	-4.42%
% of Gross Profit	60.67%	49.64%	30.82%
Depreciation & Amortization	$170.0K	$180.0K	$202.0K
YoY Change	-19.05%	-10.89%	16.09%
% of Gross Profit	19.1%	11.91%	10.66%
Operating Expenses	$2.300M	$2.594M	$2.225M
YoY Change	-39.95%	16.58%	-14.09%
Operating Profit	-$1.410M	-$1.083M	-$330.0K
YoY Change	-56.48%	228.18%	-82.95%
Interest Expense	-$1.530M	$1.531M	$1.188M
YoY Change	59.38%	28.87%	42.28%
% of Operating Profit
Other Income/Expense, Net	$0.00	$5.000K	-$15.00K
YoY Change	-100.0%	-133.33%	-98.19%
Pretax Income	-$2.950M	-$2.610M	-$2.373M
YoY Change	-29.76%	9.99%	-14.15%
Income Tax
% Of Pretax Income
Net Earnings	-$2.850M	-$2.609M	-$2.373M
YoY Change	-29.63%	9.95%	-14.15%
Net Earnings / Revenue	-146.15%	-110.79%	-58.48%
Basic Earnings Per Share
Diluted Earnings Per Share	-$359.4K	-$366.6K	-$783.5K
COMMON SHARES
Basic Shares Outstanding	7.796M
Diluted Shares Outstanding

Balance Sheet

Concept	2020 Q4	2020 Q3	2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$7.160M	$4.440M	$2.800M
YoY Change	126.58%	58.57%	26.13%
Cash & Equivalents	$7.161M	$4.436M	$2.800M
Short-Term Investments
Other Short-Term Assets	$880.0K	$770.0K	$450.0K
YoY Change	-45.0%	71.11%	55.17%
Inventory	$5.877M	$5.876M	$3.405M
Prepaid Expenses
Receivables	$1.382M	$1.698M	$4.470M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$15.30M	$12.78M	$11.13M
YoY Change	60.68%	14.83%	24.62%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.424M	$1.537M	$2.251M
YoY Change	-29.78%	-31.72%	-32.67%
Goodwill	$781.0K	$781.0K	$781.0K
YoY Change	0.0%	0.0%	-39.03%
Intangibles	$1.358M	$1.382M	$1.498M
YoY Change	-7.43%	-7.74%	-78.59%
Long-Term Investments
YoY Change
Other Assets	$48.00K	$48.00K	$48.00K
YoY Change	-77.98%	0.0%	-5.88%
Total Long-Term Assets	$5.562M	$4.513M	$6.465M
YoY Change	-2.3%	-30.19%	-48.98%
TOTAL ASSETS
Total Short-Term Assets	$15.30M	$12.78M	$11.13M
Total Long-Term Assets	$5.562M	$4.513M	$6.465M
Total Assets	$20.86M	$17.29M	$17.59M
YoY Change	37.11%	-1.72%	-18.56%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.366M	$1.661M	$1.874M
YoY Change	-5.6%	-11.37%	5.04%
Accrued Expenses	$2.430M	$2.030M	$1.800M
YoY Change	12.5%	12.78%	19.21%
Deferred Revenue	$608.0K		$840.0K
YoY Change			59.39%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$450.0K	$240.0K
YoY Change
Total Short-Term Liabilities	$6.143M	$5.720M	$5.691M
YoY Change	-8.11%	0.51%	7.36%
LONG-TERM LIABILITIES
Long-Term Debt	$6.630M	$5.930M	$4.600M
YoY Change	34.48%	28.91%	475.0%
Other Long-Term Liabilities	$20.00K	$20.00K	$23.00K
YoY Change	0.0%	-13.04%	-93.29%
Total Long-Term Liabilities	$20.00K	$20.00K	$23.00K
YoY Change	0.0%	-13.04%	-93.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.143M	$5.720M	$5.691M
Total Long-Term Liabilities	$20.00K	$20.00K	$23.00K
Total Liabilities	$14.99M	$13.99M	$12.96M
YoY Change	4.84%	7.92%	67.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$253.3M	-$250.4M	-$232.9M
YoY Change	6.9%	7.54%	5.72%
Common Stock	$9.000K	$7.000K	$3.000K
YoY Change	200.0%	133.33%	-86.36%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$5.800M	$3.132M	$3.944M
YoY Change
Total Liabilities & Shareholders Equity	$20.86M	$17.29M	$17.59M
YoY Change	37.11%	-1.72%	-18.56%

Cashflow Statement

Concept	2020 Q4	2020 Q3	2019 Q3
OPERATING ACTIVITIES
Net Income	-$2.850M	-$2.609M	-$2.373M
YoY Change	-29.63%	9.95%	-14.15%
Depreciation, Depletion And Amortization	$170.0K	$180.0K	$202.0K
YoY Change	-19.05%	-10.89%	16.09%
Cash From Operating Activities	-$2.530M	-$2.910M	-$610.0K
YoY Change	-1073.08%	377.05%	-54.14%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00	-$40.00K
YoY Change		-100.0%	-71.43%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	$0.00	$0.00	-$40.00K
YoY Change		-100.0%	-71.43%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	5.260M	350.0K	1.020M
YoY Change	5160.0%	-65.69%	64.52%
NET CHANGE
Cash From Operating Activities	-2.530M	-2.910M	-610.0K
Cash From Investing Activities	0.000	0.000	-40.00K
Cash From Financing Activities	5.260M	350.0K	1.020M
Net Change In Cash	2.730M	-2.560M	370.0K
YoY Change	658.33%	-791.89%	-143.53%
FREE CASH FLOW
Cash From Operating Activities	-$2.530M	-$2.910M	-$610.0K
Capital Expenditures	$0.00	$0.00	-$40.00K
Free Cash Flow	-$2.530M	-$2.910M	-$570.0K
YoY Change	-1073.08%	410.53%	-52.1%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
	thmo	Class Of Warrant Or Right Expired Or Cancelled During Period Weighted Average Exercise Price ClassOfWarrantOrRightExpiredOrCancelledDuringPeriodWeightedAverageExercisePrice
CY2020Q3	thmo	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	1046631
CY2020Q3	thmo	Class Of Warrant Or Right Exercisable Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightExercisableWeightedAverageExercisePriceOfWarrantsOrRights	34.42
	thmo	Class Of Warrant Or Right Exercised During Period ClassOfWarrantOrRightExercisedDuringPeriod	599582
	thmo	Class Of Warrant Or Right Exercised During Period Weighted Average Exercise Price ClassOfWarrantOrRightExercisedDuringPeriodWeightedAverageExercisePrice	2.81
	thmo	Class Of Warrant Or Right Expired Or Cancelled During Period ClassOfWarrantOrRightExpiredOrCancelledDuringPeriod
	dei	Amendment Flag AmendmentFlag	false
	dei	Document Period End Date DocumentPeriodEndDate	2020-09-30
	dei	Entity Shell Company EntityShellCompany	false
CY2020Q1	thmo	Adjustments To Additional Paid In Capital Exercise Of Prefunded Warrants AdjustmentsToAdditionalPaidInCapitalExerciseOfPrefundedWarrants	10000
CY2020Q2	thmo	Adjustments To Additional Paid In Capital Exercise Of Prefunded Warrants AdjustmentsToAdditionalPaidInCapitalExerciseOfPrefundedWarrants	22000
CY2019Q1	thmo	Adjustments To Additional Paid In Capital Exercise Of Prefunded Warrants AdjustmentsToAdditionalPaidInCapitalExerciseOfPrefundedWarrants	5000
CY2019Q2	thmo	Adjustments To Additional Paid In Capital Exercise Of Prefunded Warrants AdjustmentsToAdditionalPaidInCapitalExerciseOfPrefundedWarrants	18000
CY2019Q3	thmo	Adjustments To Additional Paid In Capital Exercise Of Prefunded Warrants AdjustmentsToAdditionalPaidInCapitalExerciseOfPrefundedWarrants	19000
	thmo	Amortization Of Accelerated Debt Discount Due To Conversion AmortizationOfAcceleratedDebtDiscountDueToConversion	2486000
	thmo	Amortization Of Accelerated Debt Discount Due To Conversion AmortizationOfAcceleratedDebtDiscountDueToConversion
CY2019Q4	thmo	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	25.23
CY2020Q3	thmo	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	37.27
	thmo	Fair Value Of Amended Convertible Note Issued FairValueOfAmendedConvertibleNoteIssued
	thmo	Fair Value Of Amended Convertible Note Issued FairValueOfAmendedConvertibleNoteIssued	1473000
	thmo	Increase Decrease In Longterm Deferrred Revenue And Other Noncurrent Liabilities IncreaseDecreaseInLongtermDeferrredRevenueAndOtherNoncurrentLiabilities	-338000
	thmo	Increase Decrease In Longterm Deferrred Revenue And Other Noncurrent Liabilities IncreaseDecreaseInLongtermDeferrredRevenueAndOtherNoncurrentLiabilities	1467000
CY2020Q3	thmo	Interest Payable Related Party Current InterestPayableRelatedPartyCurrent	1519000
CY2019Q4	thmo	Interest Payable Related Party Current InterestPayableRelatedPartyCurrent	1869000
	thmo	Inventory Change In Reserve InventoryChangeInReserve	4036000
	thmo	Inventory Change In Reserve InventoryChangeInReserve	141000
CY2020Q3	thmo	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
	dei	Document Type DocumentType	10-Q
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2020
	dei	Entity Central Index Key EntityCentralIndexKey	0000811212
CY2020Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7796170
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Registrant Name EntityRegistrantName	ThermoGenesis Holdings, Inc.
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Security12b Title Security12bTitle	Common Stock, $.001 par value
	dei	Trading Symbol TradingSymbol	thmo
CY2020Q3	thmo	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	-1526000
CY2019Q3	thmo	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	-2043000
	thmo	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	-6383000
	thmo	Nonoperating Income Expense Including Interest Expense NonoperatingIncomeExpenseIncludingInterestExpense	-4398000
	thmo	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	5580000
	thmo	Proceeds From Issuance Of Common Stock Net ProceedsFromIssuanceOfCommonStockNet	756000
	thmo	Recording Of Beneficial Conversion Feature On Debt RecordingOfBeneficialConversionFeatureOnDebt	4981000
	thmo	Recording Of Beneficial Conversion Feature On Debt RecordingOfBeneficialConversionFeatureOnDebt	2313000
CY2019Q1	thmo	Reorganization Of Subsidiary And Related Change In Noncontrolling Interest ReorganizationOfSubsidiaryAndRelatedChangeInNoncontrollingInterest
CY2019Q4	thmo	Short Term Investment Minimum ShortTermInvestmentMinimum	2000000
CY2020Q1	thmo	Short Term Investment Minimum ShortTermInvestmentMinimum	1000000
CY2020Q3	thmo	Short Term Investment Minimum ShortTermInvestmentMinimum	1000000
CY2020Q1	thmo	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	47000
CY2020Q2	thmo	Stock Issued During Period Value Exercise Of Warrants StockIssuedDuringPeriodValueExerciseOfWarrants	1604000
	thmo	Transfer Of Equipment To Inventories TransferOfEquipmentToInventories
	thmo	Transfer Of Equipment To Inventories TransferOfEquipmentToInventories	33000
CY2020Q3	thmo	Working Capital WorkingCapital	7056000
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	1661000
CY2019Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1447000
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1698000
CY2019Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1278000
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	22000
CY2019Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	2000
CY2020Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	253537000
CY2019Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	237313000
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	1869000
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	3112000
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	1513000
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature	800000
CY2020Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	67000
CY2020Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	314000
CY2020Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	234000
CY2019Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	81000
CY2019Q2	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	125000
CY2019Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	253000
CY2020Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	234000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	615000
CY2019Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	253000
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	459000
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	220000
CY2019Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	226000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	2165000
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	1799000
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8996967
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	7720081
CY2020Q3	us-gaap	Assets Assets	17289000
CY2019Q4	us-gaap	Assets Assets	15214000
CY2020Q3	us-gaap	Assets Current AssetsCurrent	12776000
CY2019Q4	us-gaap	Assets Current AssetsCurrent	9861000
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4436000
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3157000
CY2019Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4157000
CY2018Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3400000
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	4436000
CY2020Q3	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1116484
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	3800000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	279000
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	400000
CY2019Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1716066
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2019Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2019Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2019Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	350000000
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6832040
CY2019Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2843601
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6832040
CY2019Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2843601
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	7000
CY2019Q4	us-gaap	Common Stock Value CommonStockValue	3000
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2482000
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2266000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-13482000
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5441000
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-146000
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-91000
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-360000
	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-445000
CY2020Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2628000
CY2019Q3	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-2357000
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-13842000
	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-5886000
CY2020Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	115000
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	547000
CY2020Q3	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	412000
CY2019Q4	us-gaap	Convertible Notes Payable ConvertibleNotesPayable	413000
CY2020Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	844000
CY2019Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	2163000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	7426000
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	6220000
CY2020Q3	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	588000
CY2019Q4	us-gaap	Debt Instrument Unamortized Discount Noncurrent DebtInstrumentUnamortizedDiscountNoncurrent	46000
CY2019Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	620000
CY2020Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	700000
CY2019Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1901000
CY2020Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1669000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	569000
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	604000
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet
	us-gaap	Derivative Gain Loss On Derivative Net DerivativeGainLossOnDerivativeNet	-2000
CY2020Q3	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	5107000
CY2019Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	3518000
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2.36
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-2
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents	-3000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-6000
CY2020Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.37
CY2019Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-0.78
	us-gaap	Effect Of Exchange Rate On Cash And Cash Equivalents EffectOfExchangeRateOnCashAndCashEquivalents
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	513000
CY2019Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	288000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	32000
	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	15000
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-118000
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-20000
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-840000
CY2020Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt
CY2019Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-840000
CY2020Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1305000
CY2019Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1139000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	4489000
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3617000
CY2020Q3	us-gaap	Goodwill Goodwill	781000
CY2019Q4	us-gaap	Goodwill Goodwill	781000
CY2020Q3	us-gaap	Gross Profit GrossProfit	1511000
CY2019Q3	us-gaap	Gross Profit GrossProfit	1895000
	us-gaap	Gross Profit GrossProfit	371000
	us-gaap	Gross Profit GrossProfit	5105000
CY2020Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments
CY2019Q3	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	-13000
	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	223000
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-542000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	414000
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	2908000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	80000
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	354000
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-350000
	us-gaap	Increase Decrease In Due To Related Parties Current IncreaseDecreaseInDueToRelatedPartiesCurrent	-116000
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	225000
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-298000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	6086000
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-980000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-1326000
	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	-145000
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	227000
CY2020Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1382000
CY2019Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1467000
CY2020Q3	us-gaap	Interest Expense InterestExpense	1531000
CY2019Q3	us-gaap	Interest Expense InterestExpense	1188000
	us-gaap	Interest Expense InterestExpense	6377000
	us-gaap	Interest Expense InterestExpense	3531000
	us-gaap	Interest Paid Net InterestPaidNet	2094000
	us-gaap	Interest Paid Net InterestPaidNet	1613000
CY2020Q3	us-gaap	Inventory Net InventoryNet	5876000
CY2019Q4	us-gaap	Inventory Net InventoryNet	3824000
CY2020Q3	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	755000
CY2019Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	350000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1172000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	310000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	139000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	328000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	319000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	76000
CY2020Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	377000
CY2020Q3	us-gaap	Liabilities Liabilities	13987000
CY2019Q4	us-gaap	Liabilities Liabilities	14298000
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	17289000
CY2019Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	15214000
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	5720000
CY2019Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6685000
CY2020Q3	us-gaap	Long Term Notes Payable LongTermNotesPayable	411000
CY2019Q4	us-gaap	Long Term Notes Payable LongTermNotesPayable	1000000
CY2020Q3	us-gaap	Minority Interest MinorityInterest	170000
CY2019Q4	us-gaap	Minority Interest MinorityInterest	530000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	12164000
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	4096000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23000
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-178000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-11859000
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3518000
CY2020Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-146000
CY2019Q3	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-91000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-360000
	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-445000
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2463000
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2282000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13502000
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5450000
CY2020Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-4743000
CY2020Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-6510000
CY2020Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-2609000
CY2019Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-2047000
CY2019Q2	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-1475000
CY2019Q3	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	-2373000
CY2020Q3	us-gaap	Notes Payable Current NotesPayableCurrent	235000
CY2019Q4	us-gaap	Notes Payable Current NotesPayableCurrent
CY2020Q3	us-gaap	Operating Expenses OperatingExpenses	2594000
CY2019Q3	us-gaap	Operating Expenses OperatingExpenses	2225000
	us-gaap	Operating Expenses OperatingExpenses	7850000
CY2019Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-330000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7479000
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1497000
CY2020Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	135000
	us-gaap	Operating Lease Cost OperatingLeaseCost	343000
CY2020Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	766000
	us-gaap	Operating Expenses OperatingExpenses	6602000
CY2020Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1083000
CY2020Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	795000
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	648000
CY2019Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	761000
	us-gaap	Operating Lease Payments OperatingLeasePayments	225000
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	765000
CY2019Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	859000
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.22
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P3Y255D
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	48000
CY2019Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	218000
CY2020Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	38000
CY2020Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	1000
CY2020Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-19000
CY2019Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-4000
CY2019Q2	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-3000
CY2019Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	16000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	20000
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	9000
CY2020Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1092000
CY2019Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2461000
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	20000
CY2019Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	20000
CY2020Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	5000
CY2019Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-15000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	7000
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-27000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	23000
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	178000
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2019Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000
CY2019Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	2000000
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2019Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2019Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue
CY2019Q4	us-gaap	Preferred Stock Value PreferredStockValue
CY2019Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	602000
	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;"><div style="display: inline; font-style: italic;"><div style="display: inline; font-weight: bold;">Reclassifications</div></div></div> <div style=" font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:justify;">Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassifications did <div style="display: inline; font-style: italic; font: inherit;">not</div> have an impact on net loss as previously reported.</div></div></div>
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt
CY2020Q3	us-gaap	Revenues Revenues	2355000
	us-gaap	Revenues Revenues	7797000
	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1800000
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable	646000
	us-gaap	Proceeds From Notes Payable ProceedsFromNotesPayable
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	4287000
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	1513000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1683000
	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	42000
CY2019Q4	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	277000
CY2020Q3	us-gaap	Product Warranty Accrual ProductWarrantyAccrual	148000
	us-gaap	Product Warranty Accrual Payments ProductWarrantyAccrualPayments	171000
	us-gaap	Product Warranty Accrual Preexisting Increase Decrease ProductWarrantyAccrualPreexistingIncreaseDecrease	-20000
	us-gaap	Product Warranty Accrual Warranties Issued ProductWarrantyAccrualWarrantiesIssued	62000
	us-gaap	Profit Loss ProfitLoss	-13862000
	us-gaap	Profit Loss ProfitLoss	-5895000
CY2020Q3	us-gaap	Profit Loss ProfitLoss	-2609000
CY2019Q3	us-gaap	Profit Loss ProfitLoss	-2373000
CY2020Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1537000
CY2019Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2028000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-6000
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-53000
CY2020Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	750000
CY2019Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	584000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1937000
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1758000
CY2020Q3	us-gaap	Restricted Cash RestrictedCash
CY2019Q4	us-gaap	Restricted Cash RestrictedCash	1000000
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-250434000
CY2019Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-236932000
CY2020Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2355000
CY2019Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	4058000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	7797000
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11325000
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	384000
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	1257000
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	860000
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	597000
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	974000
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	4072000
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P91D
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2020Q3	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P1Y
CY2019Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	756000
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	3132000
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	386000
CY2019Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	916000
CY2020Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4605000
CY2020Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	5330000
CY2020Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	3302000
CY2019Q3	us-gaap	Revenues Revenues	4058000
	us-gaap	Revenues Revenues	11325000
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	966000
CY2020Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P7Y242D
CY2020Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	539000
CY2019Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	502000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1424000
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1227000
	us-gaap	Share Based Compensation ShareBasedCompensation	615000
	us-gaap	Share Based Compensation ShareBasedCompensation	459000
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	184137
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	17.05
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	15158
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	615500
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	291807
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	892149
CY2019Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	13.96
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.57
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	565836
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	9.91
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.13
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	5.92
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y363D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y268D
CY2020Q1	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	180000
CY2020Q2	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	189000
CY2019Q3	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	216000
CY2020Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	3221000
CY2020Q2	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1993000
CY2020Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	366000
CY2018Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6731000
CY2019Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6279000
CY2019Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	6500000
CY2019Q3	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	4631000
CY2020Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	6711664
CY2019Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2913198
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	5728105
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	2720502

Files In Submission

Name	View Source	Status
0001437749-20-023634-index-headers.html	Edgar Link	pending
0001437749-20-023634-index.html	Edgar Link	pending
0001437749-20-023634.txt	Edgar Link	pending
0001437749-20-023634-xbrl.zip	Edgar Link	pending
ex_212674.htm	Edgar Link	pending
ex_212675.htm	Edgar Link	pending
ex_212676.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
thmo-20200930.xml	Edgar Link	completed
thmo-20200930.xsd	Edgar Link	pending
thmo-20200930_cal.xml	Edgar Link	unprocessable
thmo-20200930_def.xml	Edgar Link	unprocessable
thmo-20200930_lab.xml	Edgar Link	unprocessable
thmo-20200930_pre.xml	Edgar Link	unprocessable
thmo20200930_10q.htm	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$THMO
ThermoGenesis Holdings, Inc. Stock $thmo

2020 Q4 Form 10-Q Financial Statement

#000143774920023634 Filed on November 12, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THMO ThermoGenesis Holdings, Inc. Stock $thmo

2020 Q4 Form 10-Q Financial Statement

#000143774920023634 Filed on November 12, 2020

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$THMO
ThermoGenesis Holdings, Inc. Stock $thmo